CClinicalTrials.gg
CompletedNCT00712179Updated May 13, 2016Results posted

Understanding Different Parameters in Locomotor Training (a Type of Walking Training) for Person After a Stroke

An observational study in Stroke, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-05-13.

Sponsored by VA Office of Research and Development · Observational

Study type
Observational
Time perspective
Cross-sectional
Enrollment
49
Ages
18 Years to 85 Years
Sex
All
01

Study summary

This is a research study to understand how people who have experienced a stroke walk in order to develop better and more effective types of therapy. Data collected from people who have experienced a stroke and healthy individuals will be used to compare a neurologically healthy person to someone, which has sustained an injury.

Read the detailed description

The first day will be a chance for the participants to become familiar with the body weight support (BWS) system and walking at different speeds. This first day will last about 2 hours and will consistent of fifteen total minutes of locomotor training utilizing manual trainers. This means trainers will move the participants'' body into a more normal walking pattern. The participants will be given a chance to rest between bouts; however, the participants may also rest at any point.

First, the participants will walk for five minutes at normal comfortable speed with 15% of the body weight supported through an overhead system. This will be followed by walking at speeds faster and slower than the participants' comfortable speed. After these initial bouts of stepping, will be the training bouts. Training will be conducted with 30% of the body weight supported and at speeds considered normal for adults. Trainers will assist the trunk and with each leg, and will assist with initiation of steps and leg positioning, maintenance of an upright trunk, pelvic rotation, and weight shift. Training will consist of three bouts of five minutes of stepping for a total duration of 15 minutes of stepping. Vital signs, heart rate and blood pressure, will be monitored after each 5-minute bout. If the participants wear an Ankle Foot Orthosis (AFO), the participants will be asked to walk without it, but the investigators will provide the participants with an Aircast, which supports the ankle and prevents it from rolling side to side, but allows the foot to move freely up and down ,

Data will be collected on the second day. This will take approximately five hours. During this time the participants will be asked to walk on the ground and on a treadmill. For the overground portion, the participants will walk across a 14-foot level, pressure-sensitive walkway at the participants' own speed and then as fast as the participants' can safely. This walkway measures the speed of walking and the size of steps. The participants can use any assistive device that the participants' typically use. A physical therapist or trained assistant will walk beside as the participants walk across the walkway. The participants will be asked to walk several times across the walkway at the two speeds while recordings are made from the participants' muscles and are videotaped.

The participants will also be asked to walk on a treadmill. The participants will be permitted to practice treadmill walking until the participants' feel comfortable. Once the participants feel comfortable the investigators will ask the participants to walk a couple different ways. The order will be random, and the speeds will be determined from the first visit. The participants will be asked to walk some with Body Weight Support and some without. The investigators will ask the participants to walk at the participants' comfortable speed and then as fast as the participants' can safely walk. The participants will also walk at these same speeds and percentage of body weight support while trainers help the participants step in a way as close to normal.

The participants will be able to rest at any point and for as long as they wish, however, after each trial the participants will be required to rest at least 2 minutes.

During all treadmill walking, the participants will wear a harness attached to a mobile device attached to the ceiling. This device is for safety to prevent a fall and it can catch the participants should they lose balance or stumble. It will also be used to provide body weight support for some of the walking trials. If the participants use braces and/or assistive devices, the participants will be asked to do some walking with and without them, according to the participants' comfort and safety. A therapist will walk with the participants to provide any physical assistance that may be needed.

For the walking testing, the investigators may need to shave small areas of the participants' legs to attach small sensors to the skin to measure the electrical activity of the leg muscles. The investigators will also attach reflective markers or small angle measurement devices to the skin over the participants' hips and several locations on the legs. The investigators will film the participants' movements with video cameras.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • walking
  • Treadmill
  • body weight support system
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 49 is below the median of 160 across 1,692 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Healthy Controls and persons who have sustained a stroke

Inclusion criteria

  • adults at least 18 years old;
  • able to provide informed consent;
  • able to follow three-step motor command;
  • have a single unilateral stroke;
  • medically stable (i.e. asymptomatic for bladder infection, decubiti, osteoporosis, cardiopulmonary disease, pain, or other significant medical complications that would prohibit or interfere with walking;
  • able to stand with assistance and/or ambulate 15 meters with or without an assistive device or brace and no greater than standby physical assistance.

Exclusion criteria

Exclusion Criteria:

  • weight > 300 pounds due to limitations in body weight support systems;
  • body size which is incompatible with harnesses;
  • pregnancy;
  • presence of significant musculoskeletal problems that limit hip and knee extension or ankle plantarflexion to neutral;
  • self selected walking speed below 0.3 m/s; and
  • history of congestive cardiac failure, unstable angina, or peripheral vascular disease.
05

Study design

Time perspective
Cross-sectional
Enrollment
49 participants (actual)

Groups and cohorts

  • Stroke Survivors

    Subjects walked with or with therapists' assistance at different speeds and different amounts of body weight support across conditions.

06

What researchers measure

Primary outcomes

  1. Diagnostic

    The electromyographic (EMG) gait pattern of stroke survivors was compared with "normal" pattern using z-scores.

    Time frame: During sessions- 1 day measurement

07

Results

Posted May 13, 2016

Participant flow

Participant flow — Overall Study
MilestoneStroke Survivors
Started49
Completed37
Not completed12

Outcome measures

PrimaryDiagnostic

The electromyographic (EMG) gait pattern of stroke survivors was compared with "normal" pattern using z-scores.

Time frame:
During sessions- 1 day measurement
Reported as:
Mean · Z-score
Diagnostic
Z-scoreStroke Survivors
Walking at different speeds with 15% BWS1.57 ± 0.058
Walking at self-selected speed at 0%, 15%, 30% BWS1.57 ± 0.072
Walking at different speeds with 30% BWS1.55 ± 0.075
Fastest comfortable speed with different BWS1.56 ± 0.073
Modified non-paretic leg loading and movement1.64 ± 0.079
Modified paretic leg loading and movement1.38 ± 0.061
Statistical analysis
  • Stroke Survivors · Mixed Models Analysis · p = 0.981
  • Stroke Survivors · Mixed Models Analysis · p = 0.84
  • Stroke Survivors · Mixed Models Analysis · p = 0.16
  • Stroke Survivors · Mixed Models Analysis · p = 0.073
  • Stroke Survivors · Mixed Models Analysis · p = <0.001
  • Stroke Survivors · Mixed Models Analysis · p = 0.94

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Stroke Survivors—0/37 (0%)0/37 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Stroke Survivors
<=18 years0
Between 18 and 65 years31
>=65 years18
Age, Continuous
Age, Continuous(years)Stroke Survivors
Mean61.1 ± 11.5
Sex: Female, Male
Sex: Female, Male(Participants)Stroke Survivors
Female13
Male36
Region of Enrollment
Region of Enrollment(participants)Stroke Survivors
United States49
Baseline walking speed
Baseline walking speed(meters per second)Stroke Survivors
Mean0.59 ± 0.23
08

Study locations

1 site
  • North Florida/South Georgia Veterans Health System
    Gainesville, Florida 32608, United States
09

References and documents

Publications

  • Srivastava S, Patten C, Kautz SA. Altered muscle activation patterns (AMAP): an analytical tool to compare muscle activity patterns of hemiparetic gait with a normative profile. J Neuroeng Rehabil. 2019 Jan 31;16(1):21. doi: 10.1186/s12984-019-0487-y. PubMed 30704483 ↗

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00712179
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Jul 9, 2008
Start date
Jul 2008
Primary completion
Oct 2011
Completion
Dec 2013
Results posted
May 13, 2016
Last update
May 13, 2016

Study contacts

Steve A. Kautz, PhD MS BS
principal investigator · Ralph H. Johnson VA Medical Center, Charleston, SC

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion